Table of Contents

• R M Cohen

Implications of linking pharmacy and laboratory data to assess diabetes care.

• S Aronoff,
• S Rosenblatt,
• S Braithwaite,
• J W Egan,
• A L Mathisen,
• and R L Schneider

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

• R Taylor,
• R Davies,
• C Fox,
• M Sampson,
• J U Weaver,
• and L Wood

Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.

The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

• R A Bell,
• E J Mayer-Davis,
• M A Martin,
• R B D'Agostino, Jr,
• and S M Haffner

Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.

• H P Wetzler and
• J W Snyder

Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes.

• H E Resnick,
• A I Vinik,
• A V Schwartz,
• S G Leveille,
• F L Brancati,
• J Balfour,
• and J M Guralnik

Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.

• D L Sprecher,
• G L Pearce,
• E M Park,
• F J Pashkow,
• and B J Hoogwerf

Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.

• G A Nichols,
• H S Glauber,
• and J B Brown

Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis.

• E S Horton,
• C Clinkingbeard,
• M Gatlin,
• J Foley,
• S Mallows,
• and S Shen

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

• P Raskin,
• L Klaff,
• R Bergenstal,
• J P Hallé,
• D Donley,
• and T Mecca

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

• R M Voutilainen-Kaunisto,
• M E Teräsvirta,
• M I Uusitupa,
• and L K Niskanen

Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance.

• R Boizel,
• P Y Benhamou,
• B Lardy,
• F Laporte,
• T Foulon,
• and S Halimi

Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.

• S Mäkimattila,
• A Schlenzka,
• M Mäntysaari,
• R Bergholm,
• P Summanen,
• P Saar,
• H Erkkilä,
• and H Yki-Järvinen

Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.

• D Feng,
• S E Bursell,
• A C Clermont,
• I Lipinska,
• L P Aiello,
• L Laffel,
• G L King,
• and G H Tofler

von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.

• Z T Bloomgarden

American Diabetes Association 60th Scientific Sessions, 2000: diabetes and pregnancy.

• Y Nagai,
• T Hayakawa,
• T Abe,
• and G Nomura

Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?

• T S Tai,
• W H Sheu,
• W J Lee,
• H T Yao,
• and M T Chiang

Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.

• M Tang and
• Y Chen

Prevalence of diabetes in Canadian adults aged 40 years or older.

• M L Mitchell,
• R J Hermos,
• C A Larson,
• G E Palomaki,
• and J E Haddow

Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.

• J Vetiska,
• L Glaab,
• K Perlman,
• and D Daneman

School attendance of children with type 1 diabetes.

• T Lohmann,
• U Nietzschmann,
• and W Kiess

"Lady-like": is there a latent autoimmune diabetes in the young?

• M Rose,
• M Hildebrandt,
• H Fliege,
• B Seidlitz,
• L Cotta,
• T Schirop,
• and B F Klapp

Relevance of the treatment facility for disease-related knowledge of diabetic patients.

The Met416-->Val variant in the glycogen synthase gene: the prevalence and the association with diabetes in a large number of Japanese individuals. Study Group for the Identification of Type 2 Diabetes Genes in Japanese.

• F Lithner

Venlafaxine in treatment of severe painful peripheral diabetic neuropathy.

• D Stöckl,
• K Dewitte,
• C Fierens,
• and L M Thienpont

Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line".

• C J Caspersen,
• M M Zack,
• and J E Fulton

Moderate-intensity physical activity and fasting insulin levels in women.

• W Taha,
• I Paz-Priel,
• and H Anhalt

Are tumor necrosis factor-alpha receptor 2 levels associated with age?

• R Matz

Hypoglycemia, seizures, and pulmonary edema.

• G Carreras,
• D Mauricio,
• A Pérez,
• and A de Leiva

Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?